Simulations Plus (SLP) News Today

Simulations Plus, Inc. (NASDAQ:SLP) shares rose today as a series of analyst updates and market signals highlighted both near-term headwinds and longer-term growth drivers for the drug-development software specialist.

• Positive Sentiment: William Blair raised its FY2025 EPS forecast to $0.97 (from $0.90) and maintained an “Outperform” rating William Blair Lifts Earnings Estimates for Simulations Plus
• Positive Sentiment: An unusually high volume of call options traded in SLP, suggesting bullish interest among options traders Stock Traders Purchase High Volume of Call Options on Simulations Plus
• Positive Sentiment: A Seeking Alpha analysis highlighted Simulations Plus’s strong positioning in the FDA’s growing “in-silico” drug-development trend as a long-term catalyst Simulations Plus: Still Positioned For FDA In-Silico Trend Despite Near-Term Headwinds
• Neutral Sentiment: KeyCorp kept a “Sector Weight” rating while forecasting Q1 2026 EPS of $0.19 KeyCorp Predicts Simulations Plus' Q1 Earnings
• Neutral Sentiment: KeyCorp set its FY2025 EPS estimate at $1.01, modestly below consensus FY2025 Earnings Forecast for SLP Issued By KeyCorp
• Negative Sentiment: William Blair trimmed its FY2026 EPS outlook to $0.86 (from $0.99) despite keeping an “Outperform” rating What is William Blair's Forecast for SLP FY2026 Earnings?
• Negative Sentiment: Stephens issued a pessimistic price forecast for SLP, citing near-term headwinds and valuation concerns Stephens Issues Pessimistic Forecast for Simulations Plus (NASDAQ:SLP) Stock Price